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STRUBBE, J. H., J. G. WOLSINK, A. M. SCHUTTE, B. BALKAN AND A. J. A. PRINS. Hepatic-portal nd cardiac infusion 
of CCK-8 and glucagon induce different effects on feeding. PHYSIOL BEHAV 46(4) 643~:r46, 1989.--In order to compare ffects 
of circulating CCK-8 and glucagon on food intake, rats were provided with a permanently implanted catheter in the right atrium. 
Another cannula was implanted into the hepatic-portal vein by a new technique. After a standard fasting period graded loads of CCK-8 
and glucogon were infused via these catheters during refeeding. Intracardiac glucagon and CCK loads dose-dependently suppressed 
meal size. Intraportal infusion of glucagon caused similar suppression compared to intracardiac administration. This may indicate a 
minor ole of the liver as a target for the suppression of feeding by glucagon. In contrast, intraportal infusion of CCK-8 did not reduce 
food intake. The results indicate that CCK-8 is removed or inactivated by the liver. It is suggested that CCK-8 acts locally on vagat 
nerve endings to exert its suppressive action on food intake. 
Food intake Satiety CCK-8 Glucagon Liver Hepatic portal vein 
CHOLECYSTOKININ and glucagon are proposed to be satiety 
signals in the control of food intake (5, 10, 11, 25). Since CCK is 
secreted by the intestines and glucagon mainly by the pancreas 
they reach the liver via the hepatic-portal vein. To test the satiety 
hypothesis, CCK and glucagon should depress food intake when 
they are infused into the portal vein. Recently some doubt raised 
whether CCK acts via this route, as intraportal infusion of CCK-8 
caused very little suppression of food intake in rats (7,8). In many 
studies in this field glucagon and CCK-8 were administered by 
intraperitoneal injection (4, 5, 10, 11). Although after intraperi- 
toneal injection these hormones are taken up rapidly into the portal 
circulation they may exert their suppressive ffects by a direct 
influence on the serosal side of the intestines (7,18). Some 
evidence exists that in rats intraportally injected glucagon is 
effective in suppressing food intake (12,25), probably via afferent 
vagal pathways (13). 
However, the comparison with infusion in the general circula- 
tion is needed to shed more light on the satiety effects of CCK-8 
and glucagon and the possible site of action. Therefore graded 
loads of glucagon and CCK-8 were infused during feeding after 
moderate fasting periods via permanently implanted cannulas into 
the right atrium and hepatic portal vein in rats. 
METHOD 
Animals and Housing 
Male Wistar rats (350-400 g) were kept in a sound attenuated 
room on a light-dark regime (LD 12:12). For practical reasons 
lights were on from 0-12 hr and off from 12-24 hr. The rats were 
housed individually in perspex cages. Food pellets of rat chow 
(Hope Farms, The Netherlands) were available ad lib unless 
otherwise stated. Room temperature was thermostatically con- 
trolled at 21 _0.2°C. 
Cannulation Technique 
The rats were provided with a jugular vein catheter with the tip 
in the right atrium (20). During the same surgery procedure, the 
rats were provided with a permanent cannula for infusion into the 
portal vein. During the last decade we developed this new surgical 
technique. This technique has three main advantages over other 
techniques (16, 17, 23, 24) described in the past: 1) disturbances 
to intestinal blood flow are minimal because only a very small part 
of the cannula is inserted in the widest part of the portal vein, 2) 
cannula longevity is enhanced such that cannulas can be used for 
at least one month for blood sampling and for at least 2 months for 
infusion, 3) no special stitch techniques as used in microsurgery 
are required. In the following paragraphs this technique will be 
described shortly. 
The preparation of the cannula. A silastic medical-grade 
tubing (Dow Coming, Midland, MI, Silastic 602-135, i.d. 0.51 
mm, o.d. 0.94 mm) of 22 cm is beveled at one end to a point. At 
a distance of l mm from the tip a hole was cut with a sharp cut 20 
ga needle. Two rings of silicon glue were placed at l0 mm and at 
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40 mm from the cannula tip. Cannulas were sterilized before 
surgery. 
Surgery 
The sterilized cannula was filled with heparin solution in saline 
(500 U/ml). Under ether anesthesia the ventral abdominal wall was 
exposed. The hairs at the place of the incision, i.e., 2-4 cm caudal 
to the xyphoid process, were removed. The skin was sterilized 
with a chlorhexidine solution. A midline incision of about 3 cm 
was made and the duodenal loop was turned, so that the portal vein 
was exposed. The venous part of the superior mesenteric vein 
between the entrance of the gastroduodenal nd superior pancre- 
atico-duodenal vein was clamped very shortly (1-2 min). With a 
20 ga needle a hole was made in the middle of this venous 
compartment. Immediately thereafter the cannula tip was inserted 
and pushed downstream till the silicon ring touched the vein. The 
clamps were removed and the cannula tip was situated in the main 
stream of the portal vein. A piece of silk thread (7-0, Ethycon 
Perma Hand Seide) was fixed just behind the silicon ring. The 
loose ends of the thread were slipped under the vein and tied in 
such a way that the blood stream was not hindered. The second 
silicon ring in the cannula was fixed onto the abdominal wall. This 
ring prevents tension on the just implanted cannula. The cannula is 
inserted under the skin and drawn to the skull where it is connected 
to a stainless teel tubing (20 ga). Subsequently, the cannula is 
anchored onto the skull with dental cement and filled with 50% 
w/v polyvenylpyrrolidon (mol.wt. 25,000, Merck) in a heparine 
solution 500 IU/ml as described earlier (20). The rats were allowed 
to recover for about a week from surgery before they were used in 
the experiments. 
Feeding Behavior 
Rats were enabled to gnaw food through vertical stainless teel 
bars situated in front of a food hopper. Spillage was collected in an 
undertray attached to the food hopper. Each food hopper's weight 
was sampled by a programmed microprocessor every tenth of a 
second. Every second the mean weight was calculated and stored 
on a magnetic assette tape. From this a computer etrieved the 
size and timing of meals. An Esterline Angus event recorder was 
used to monitor feeding behavior directly, thereby obtaining a 
visual check on the computer data. Feeding sequences of at least 
1 minute which were separated from each other by nonfeeding 
intervals longer than 15 minutes were considered as separate 
meals. 
Experimental Procedures 
Access to food was restricted by means of an automatic 
horizontally sliding door situated in front of a food hopper. The 
rats were deprived of food over the light phase and in addition over 
the first 2 hr of the dark phase. Immediately after opening of the 
doors they ate a large meal of fairly constant size and duration of 
about 20 minutes. The effect of CCK and glucagon infusions was 
tested on this meal. Previous work has shown that at this time there 
is minimal interaction with the circadian control of feeding 
behavior (22). Moreover, this method leaves the meal pattern in 
the other part of the night unaffected. Therefore, this method is 
less disturbing for a rat than the often used overnight fast. 
Infusions 
In order to prevent disturbances in the experiment by handling 
the animals or by entering the experimental room, the rats were 
connected with the pump 4 hr before the end of the deprivation. 
This connection occurred by attaching a long polyethylene tubing 
on the catheters ending on the skull. The tubing was kept tight by 
a counterweight. A small swivel joint prevented torsion of the 
tubing and a stainless teel spring around the tubing protected it
against biting (21). The door in front of the food hopper and the 
infusion pump were activated simultaneously. The rats were 
habituated to the infusion procedure for about a week with saline 
infusions (0.9% NaC1 w/v) until they ate a constant amount of 
food during the first meal after deprivation. Intraportal and 
intracardiac infusions of glucagon and saline were randomly given 
to the same animals (n = 6). Thereafter, the same approach was 
used for CCK and saline (n = 6) in the same animals. 
Solutions. The hormones were dissolved in saline 0.9% NaC1 
w/v. In order to prevent binding of the hormones to the walls of the 
infusion system, we added 0.1% w/v bovine serum albumin to the 
solution. The rate of infusion was 0.075 ml/min. Glucagon 
(NOVO) infusions of 75, 150 and 300 p~g/kg/hr were given 
intravenously and 30, 75, 150 and 300 p.g/kg/hr via intraportal 
routes. Intravenous infusions of CCK-8 (sulphated, Sigma) of 1.0, 
1.5, 3.0, 9.0 and 15 Ixg/kg/hr and portal infusions at a rate of 3.0, 
9.0, and 15 Ixg/kg/hr were given. All loads were tested twice. 
After these experiments the rats were subjected to another 
surgery. A small incision in the abdominal wall was made in order 
to localize the portal vein cannula. At that time we had a visual 
check on the proper functioning of the portal vein cannula. By 
giving a saline injection into all cannulas we had a check on 
possible leakage of these cannulas. In the experimental group no 
leakage was observed. In some cases blood could be withdrawn. 
This cannula was cut and the part connected with the portal vein 
was tied off, so that the remaining part was suitable for intraperi- 
toneal infusion. After recovery from surgery intraperitoneal infu- 
sions of saline and CCK (9 p.g/kg/hr) were given. 
Data Analysis 
MANOVA was applied to all data with dose as covariant. Dose 
response relations were tested by a Spearman rank correlation. As 
individual differences contributed substantially to the total vari- 
ance, statistics on the drug and dose effects are applied to the 
percentages of the control values, i.e., food consumed uring 
infusion of saline. Spearman Rank correlation and paired t-test 
two-sided were applied to the means of the two tests for all 
animals, doses and routes tested. 
RESULTS 
MANOVA on the complete dataset revealed a high variance in 
individual intakes and interactions between animal and route of 
administration as well as the hormone given. For that reason all 
intakes were recalculated as percentages of the mean of two 
control meals (i.e., during saline infusion) taken by each individ- 
ual animal nearest in time to that particular experiment. Mean food 
intake during saline infusions of the glucagon test amounted to 
4.9 +0.2 g and 5.3 -+0.2 g (n = 12) for intracardiac and intraportal 
administration, respectively. For the CCK-8 experiment hese 
values amounted to 6.1 -+0.4 and 5.0-+0.3 g (n= 12), respec- 
tively. During glucagon infusion all doses caused significant 
suppression of food intake [MANOVA: F(1,69)=72, p<0.001] 
(Fig. 1). Spearman rank correlation between dose and percentage 
of the food taken relative to that taken during saline infusion was 
significant for both infusion routes via the jugular vein (n = 24, 
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FIG, 1. Satiety effect of graded loads of glucagon expressed as percentage 
of control intake when infused into the right atrium (O) or into the portal 
vein (©) (mean+SEM, n=6). 
r= - .7 ,  p<0.005) and portal vein (n= 30, r= - .7 ,  p<0.005). 
There was a dose-dependent suppression of food intake when 
CCK-8 was administered into the right atrium. The correlation 
between CCK-8 dose and percentage of food intake was signifi- 
cant (n=36, r=- .8 ,  p<0.001) (Fig. 2). In contrast, when 
CCK-8 was infused into the portal vein no dose-response effect 
was found (n = 24, r= .2, p = 0.27) nor was any significant effect 
seen of the drug with a paired t-test between intake in grams during 
saline infusion and portal infusion of the higher doses (Fig. 2), 
i.e., for 9 Ixg/kg/hr (n=6,  p =0.27) and for 15 ixg/kg/hr (n=6,  
p=0.7) ,  or computed for relative intakes with the same doses: 9 
txg/kg/hr (n = 6, p = 0.6) and 15 ~g/kg/hr (n = 6, p = 0.80). There 
was a significant suppression of food intake after intraperitoneal 
administration of 9 txg/kg/hr CCK-8, resulting in 52--- 6% of the 
intake during saline infusion (n=6,  p<0.01). Total daily food 
intake was not affected by any of the treatments. The reason for 
this is probably the short half-life of the hormones. During the rest 
of the night-time there is enough time to compensate for the 
relatively small reductions of food intake. 
DISCUSSION 
These experiments clearly show that glucagon caused similar 
suppression during intraportal and intracardiac infusion, whereas 
CCK-8 only reduced food intake when administered into the 
general circulation or into the abdominal cavity. For obvious 
reasons the liver will sense much higher plasma glucagon concen- 
trations when glucagon is administered in the portal vein compared 
with infusion into the general circulation. Yet there is no differ- 
ence in effect. This may indicate that a functional target for the 
suppressive ffects of glucagon could be outside the liver. In this 
respect it has been reported that intraportal glucagon is a potent 
stimulus for insulin secretion (26). Since insulin may have satiety 
effects (15), it could be a potential mediator of glucagon-induced 
inhibition of feeding (26). There is also evidence that vagal 
afferents are involved in glucagon-induced suppression of food 
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FIG. 2. Satiety effect of graded loads of CCK-8 expre~ed as percentage of
control intake when infused into the right atrium (O) or irtto the portal vein 
(©) (mean --- SEM, n = 6). 
suppression of food intake by intraperitoneal g ucagon injections 
was blocked by selective denervation of the liver, suggesting that 
the target for the suppressive effects of glucagon on food intake is 
located in the liver (4). Further experiments are needed using 
blood sampling and plasma assaying of glucagon to establish 
whether glucagon reaches physiological levels during the infu- 
sions. 
The absence of any reduction when CCK-8 was intraportally 
infused suggests that intraportal CCK-8 may not suppress feeding 
under normal physiological conditions. In contrast, the present 
study also shows that intraperitoneal dministration caused strong 
suppressions of food intake, thereby confirming others (5, 7, 8). 
This may indicate that CCK-8 given via this route may act on 
intraabdominal receptors or probably on the serosal side of the 
intestines or stomach. There is indeed much evidence that CCK-8 
inhibits stomach emptying rate (1,18) and activates intestinal 
motility (18). Moreover, cutting branches of the vagus nerve to the 
stomach decreased CCK-8 induced anorexia (19). It is very likely 
that intravenously given CCK-8 acts on the same place although 
other areas like the brain and vagus nerve are also potential 
candidates (14, 28, 29). But how does CCK-8 act when it is not 
passing the liver in an active form? One possibility is a local 
paracrine action as suggested by others (7,8). It is also possible 
that CCK-8 is released as a hormone to the portal circuit and 
reaches by way of diffusion or via arteriovenous connections in the 
intestines the target areas for CCK. There is some evidence that 
the liver clearance of the larger hormone CCK-33 is slower than 
that of CCK-8 (2,6), which may result in low peripheral levels of 
CCK-8. Therefore, intraportal CCK-33 may be more effective 
than the octapeptide. CCK-8 has been found in significant quan- 
tities in plasma (3), but the precise origin is difficult to ascertain 
(27). Considering the available vidence the most likely possibility 
is that CCK-8 acts locally on vagal sensory nerve endings to exert 
its suppressive action on food intake. 
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